INSIGHTS ON DRUG DEVELOPMENT
-
LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting
Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.
-
Optimizing Yield, Purity, And Scalability In A Cost-Effective Manner During Process Development
Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.
-
Optimization And Scale-Up Of A Plasmid DNA Production Process
Optimizing pDNA production in E. coli requires strategic media selection and scale-up planning. Explore a study that identifies ideal conditions for high-yield manufacturing.
-
Patented Process For Intermediates Useful For Deucravacitinib
Discover how this patented synthetic approach to Deucravacitinib intermediates can improve yield, simplify purification, and support scalable, regulatory-aligned manufacturing.
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue5/6/2026
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and de‑risk innovative programs through early dialogue.
-
Imagine The Future: An Enhanced Oligonucleotide Synthesis Process2/9/2026
Gain practical guidance for improving oligo quality, see how an advanced synthesis platform supports production, and explore a software interface designed to make daily operations more intuitive.
-
Development Of Separation Methods for GLP-1 Synthetic Peptides6/27/2025
Peptides offer precise, low-cost therapeutic potential, especially in GLP-1 drugs for diabetes and weight loss. A new HPLC-UV/MS method ensures consistent quality and analysis of these compounds.
-
Making Accelerated Predictive Stability Studies Even Faster With Software6/18/2026
Drug stability depends on environmental conditions, but testing every scenario experimentally isn’t practical. Accelerated predictive stability uses mathematical modeling to forecast degradation, helping scientists make faster, data-driven decisions early in development.
-
Biopharma Production And Quality Control With Electrophoresis2/20/2025
Discover how Kaneka Eurogentec, a leading provider of custom DNA synthesis and molecular biology services, enhanced their fragment analysis to achieve higher efficiency and accuracy in their workflows.
DRUG DEVELOPMENT SOLUTIONS
-
Explore this interactive PDF with information about technologies & end-to-end integrated CDMO services provided by Adare Pharma Solutions.
-
AI-driven co-crystal prediction accelerates solubility optimization by identifying ideal co-formers in days without needing the drug substance. Learn how to save time, reduce costs, and boost formulation success.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
The iCELLis™ bioreactor system is an automated, single-use, fixed-bed bioreactor that provides excellent cell growth conditions for adherent cells.
-
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.